YWYajing Wang

Yajing Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yajing Wang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Dongmei Wei

    Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, 610041 Chengdu, Sichuan, China

    3 shared publications
  • Jian Meng

    Department of Obstetrics and Gynecology, West China Second University Hospital Sichuan University Chengdu Sichuan China

    3 shared publications
  • Qiao Li

    Department of Obstetrics and Gynecology, West China Second University Hospital Sichuan University Chengdu Sichuan China

    3 shared publications
  • Yueyue Chen

    Department of Obstetrics and Gynecology, West China Second University Hospital Sichuan University Chengdu Sichuan China

    3 shared publications
  • Xiaoyu Niu

    Department of Obstetrics and Gynecology West China Second University Hospital Sichuan University Chengdu Sichuan China

    2 shared publications
  • Aaron Diantonio

    Department of Developmental Biology, Washington University School of Medicine

    1 shared publication

Latest Publications

  • Open Access

    Fractional CO 2 Laser Treatment for Female Vaginal Relaxation Syndrome: A Prospective Study

    by Qiao Li, Jian Meng, Yajing Wang, Yueyue Chen, Xiaoyu Niu, Dongmei Wei

    Background: Vaginal relaxation syndrome (VRS) is a common condition that adversely affects women's quality of life. Conventional non‐surgical therapies provide limited benefit for patients with mild to moderate disease. Fractional CO 2 laser (FxCO 2 ) therapy has emerged as a minimally invasive treatment option; however, its long‐term efficacy and safety remain to be fully elucidated. Objective: To prospectively evaluate the efficacy and safety of FxCO 2 in women with mild to moderate VRS. Methods: This prospective self‐controlled study enrolled 101 women diagnosed with mild to moderate VRS. All participants underwent three sessions of FxCO 2 treatment at 4‐week intervals. Clinical outcomes were assessed at baseline and at 1, 3, 6, and 12 months after the final treatment using the Female Sexual Function Index (FSFI), Vaginal Laxity Questionnaire (VLQ), and Vaginal Health Index (VHI). Adverse events were recorded throughout the follow‐up period. Results: All primary outcome measures improved following treatment. The mean FSFI total score increased from 21.4 to 25.9, the VLQ score improved from 2.68 to approximately 3.0, and the VHI score increased from 17.0 to 19.25 (all p < 0.001). Subgroup analyses indicated that treatment efficacy was not significantly influenced by parity, age, or the presence of concomitant urinary incontinence. Only mild and transient adverse events were reported, all of which resolved spontaneously. Conclusions: FxCO 2 therapy effectively improves sexual function, subjective vaginal tightness, and vaginal mucosal health in women with vaginal relaxation syndrome. The short‐term efficacy is favorable, with no significant safety concerns observed.


  • Open Access

    Fractional CO 2 Laser Combined With Topical Corticosteroids for Vulvar Lichen Simplex Chronicus: An Observational Study From an 8‐Year Single‐Center Experience

    by Dongmei Wei, Jian Meng, Yanjun Zhu, Qiao Li, Yajing Wang, Yueyue Chen, Xiaoyu Niu

    Background: Vulvar lichen simplex chronicus (VLSC) is a chronic inflammatory dermatosis that remains difficult to manage long term. Fractional CO 2 laser (FxCO 2 ) combined with topical corticosteroids (TCs) has emerged as a potential therapeutic strategy; however, high‐quality long‐term evidence remains limited. Objective: To evaluate the long‐term efficacy and safety of FxCO 2 combined with TC in patients with VLSC. Study Design: This retrospective single‐center study included 172 patients with biopsy‐confirmed VLSC treated between 2016 and 2024. All patients received at least one FxCO 2 + TC treatment session. Primary outcomes included pruritus improvement, recurrence, and subjective symptom relief. Secondary outcomes assessed patient satisfaction, treatment adherence, and adverse events. Results: FxCO 2 combined with TC treatment was effective, achieving an initial pruritus improvement rate of 90.12% (155/172). Subjective symptom improvement was reported by 91.86% (158/172) of patients, and patient satisfaction was 88.95% (153/172). Among those who improved, 50.58% (80/155) achieved improvement after 3 treatments, and the median duration of improvement was 18.0 months (range, 12–54 months). The recurrence rate was 14.84% (23/155), with a median time to recurrence of 36.0 months (range, 12–60 months). Adverse events occurred in 15.70% (27/172) of patients, with dryness being the most common (6.40%, 11/172). No clinical signs of deterioration or atypical progression were noted throughout the follow‐up. Conclusion: FxCO 2 combined with TC treatment is effective and well tolerated in women with VLSC, providing long‐term symptom relief with low recurrence and acceptable safety. This combined approach may represent a promising therapeutic option for managing intense pruritus associated with VLSC.


  • Open Access

    Efficacy and Safety of Laser Treatment in Vulvar Lichen Sclerosus: A Systematic Review

    by Dongmei Wei, Jian Meng, Qiao Li, Yajing Wang, Yueyue Chen, Xiaoyu Niu

    Objectives: This study systematically reviews randomized controlled trials (RCTs) evaluating laser therapy for vulvar lichen sclerosus (VLS) to assess its efficacy and safety, aiming to inform clinical management and guideline development. Methods: RCTs on laser treatment for VLS were retrieved from PubMed, Embase, Web of Science, and Cochrane databases up to January 2025, limited to English literature. References from included studies were also screened. Data on study characteristics, laser parameters, outcome measures, measurement tools, and assessment time points were extracted and analyzed. Results: Seven RCTs (332 patients) reported 19 outcomes and 19 measurement tools, each used a total of 28 times. Symptoms and signs were most frequently reported and commonly measured using the Visual Analog Scale (VAS). Most trials indicated improvements in symptoms, signs, quality of life (QoL), and histology after laser therapy. Three studies reported greater symptom/sign improvement than topical corticosteroids ( p < 0.05), and three found higher patient satisfaction ( p < 0.05). Two studies showed good tolerability via VAS. Adverse events occurred in five studies (147 patients), including five mild cases (local irritation, blisters, urinary tract infection, itching, and pain). Due to heterogeneity and low study quality, a meta‐analysis was not performed. Conclusions: Laser therapy improves symptoms/signs, QoL, and histological outcomes in VLS, with good safety and tolerability. However, the evidence supporting its use as a monotherapy is limited, and benefits for anti‐inflammatory, anti‐fibrotic, scar‐preventive, or anticarcinogenic effects remain unproven. Large‐scale, long‐term, and high‐quality trials are needed, and future research should establish standardized Core Outcome and Measurement Sets to optimize VLS management.


  • Open Access

    The structure of NAD + consuming protein Acinetobacter baumannii TIR domain shows unique kinetics and conformations

    by Erik Klontz, Juliet O. Obi, Yajing Wang, Gabrielle Glendening, Jahid Carr, Constantine Tsibouris, Sahthi Buddula, Shreeram Nallar, Alexei S. Soares, Dorothy Beckett, et al.

    Toll-like and Interleukin-1/18 receptor resistance (TIR) domain-containing proteins function as important signaling and immune regulatory molecules. TIR domain-containing proteins identified in eukaryotic and prokaryotic species also exhibit NAD+ hydrolase activity in select bacteria, plants, and mammalian cells. We report the crystal structure of the Acinetobacter baumannii TIR domain protein (AbTir-TIR) with confirmed NAD + hydrolysis and map the conformational effects of its interaction with NAD + using HDX-MS. NAD + results in mild decreases in deuterium uptake at the dimeric interface. In addition, AbTir-TIR exhibits EX1 kinetics indicative of large cooperative conformational changes which are slowed down upon substrate binding. Additionally, we have developed label-free imaging using 2pFLIM which shows differences in bacteria expressing native and mutant NAD+ hydrolase-inactivated AbTir-TIR EA protein. Our observations are consistent with substrate-induced conformational changes reported in other TIR model systems with NAD+ hydrolase activity. These studies provide further insight into bacterial TIR protein mechanisms and their varying roles in biology.

  • Factors associated with venous thromboembolism in the paediatric intensive care unit: A systematic review and meta‐analysis

    by Ya Jing Wang, Lei Lei, Yan Huang

    Background: Paediatric critical care practitioners have become increasingly concerned about venous thromboembolism (VTE). Although a wide range of factors associated with VTE in paediatric intensive care units (PICUs) have been identified, the strength and consistency of effect sizes are uncertain.Study Design: Systematic review and meta‐analysis of case–control and cohort studies.We searched six electronic databases from inception to 20 June 2021. The study population consisted of hospitalized children aged 0–21 years. Our primary outcome was factors associated with VTE in the PICU. We pooled effect sizes as odds ratios (ORs) using random‐effects models for each factor that was examined in at least three distinct samples. We assessed study quality using the Newcastle–Ottawa Scale and examined between‐study heterogeneity.Results: The meta‐analysis showed that age <1 year (OR = 1.80, 95% confidence interval [CI]: 1.08–3.01), sepsis (OR = 3.14, 95% CI: 1.55–6.38), central venous catheterization (CVC; OR = 7.76, 95% CI: 3.63–16.61), and mechanical ventilation (OR = 2.80, 95% CI: 1.90–4.13) was associated with an increased VTE risk.Conclusion: We identified that infancy, sepsis, and the use of CVC and mechanical ventilation therapies are more likely to cause VTE in critically ill children. It is still necessary to identify the association between VTE and important clinical variables (e.g., postpubertal age, postoperative status).Relevance to Clinical Practice: This review provides evidence that supports the factors associated with VTE in specific clinical settings and suggests that nurses should focus on the precise identification of the factors associated with VTE.